Phospholipase A2-like activity of human bocavirus VP1 unique region

Biochemical and Biophysical Research Communications

Volumn 365, Issue 1, 2008, Pages 158-163

  Qu, Xiao Wang ^a   Liu, Wen Pei ^a   Qi, Zheng Yu ^a   Duan, Zhao Jun ^a   Zheng, Li Shu ^a   Kuang, Zi Zhou ^a   Zhang, Wan Ju ^a   Hou, Yun De ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Human bocavirus; Phospholipase A2; Point mutation; VP1 unique region

Indexed keywords

4 BROMOPHENACYLBROMIDE; ASPARTIC ACID; CALCIUM ION; HISTIDINE; MANOALIDE; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; PROLINE; PROTEIN VP1; PROTEIN VP1U; UNCLASSIFIED DRUG; VIRUS PROTEIN; 4 BROMOPHENACYL BROMIDE; 4-BROMOPHENACYL BROMIDE; ACETOPHENONE DERIVATIVE; CALCIUM; TERPENE;

ANTIVIRAL ACTIVITY; ARTICLE; BOCAVIRUS; ENZYME ACTIVITY; ENZYME INHIBITION; ESCHERICHIA COLI; GENE MUTATION; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT INFECTION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; VIRUS MORPHOLOGY; AMINO ACID SEQUENCE; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; MUTATION; PROTEIN MOTIF; VIRUS INFECTION;

HUMAN BOCAVIRUS; PARVOVIRUS;

ACETOPHENONES; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; BOCAVIRUS; CALCIUM; CLONING, MOLECULAR; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PHOSPHOLIPASES A2; TERPENES; VIRAL PROTEINS;

EID: 36048935949     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.10.164     Document Type: Article

References (27)

1. Allander T., Tammi M.T., Eriksson M., Bjerkner A., Tiveljung-Lindell A., and Andersson B. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc. Natl. Acad. Sci. USA 102 (2005) 12891-12896
2. Arnold J.C., Singh K.K., Spector S.A., and Sawyer M.H. Human bocavirus: prevalence and clinical spectrum at a children's hospital. Clin. Infect. Dis. 43 (2006) 283-288
3. Bastien N., Brandt K., Dust K., Ward D., and Li Y. Human Bocavirus infection, Canada. Emerg. Infect. Dis. 12 (2006) 848-850
4. Foulongne V., Rodiere M., and Segondy M. Human Bocavirus in children. Emerg. Infect. Dis. 12 (2006) 862-863
5. Weissbrich B., Neske F., Schubert J., Tollmann F., Blath K., Blessing K., and Kreth H.W. Frequent detection of bocavirus DNA in German children with respiratory tract infections. BMC Infect. Dis. 6 (2006) 109
6. Ma X., Endo R., Ishiguro N., Ebihara T., Ishiko H., Ariga T., and Kikuta H. Detection of human bocavirus in Japanese children with lower respiratory tract infections. J. Clin. Microbiol. 44 (2006) 1132-1134
7. Qu X.W., Duan Z.J., Qi Z.Y., Xie Z.P., Gao H.C., Liu W.P., Huang C.P., Peng F.W., Zheng L.S., and Hou Y.D. Human bocavirus infection, People's Republic of China. Emerg. Infect. Dis. 13 (2007) 165-168
8. Sloots T.P., McErlean P., Speicher D.J., Arden K.E., Nissen M.D., and Mackay I.M. Evidence of human coronavirus HKU1 and human bocavirus in Australian children. J. Clin. Virol. 35 (2006) 99-102
9. Smuts H., and Hardie D. Human bocavirus in hospitalized children, South Africa. Emerg. Infect. Dis. 12 (2006) 1457-1458
10. Allander T., Jartti T., Gupta S., Niesters H.G., Lehtinen P., Osterback R., Vuorinen T., Waris M., Bjerkner A., Tiveljung-Lindell A., van den Hoogen B.G., Hyypia T., and Ruuskanen O. Human bocavirus and acute wheezing in children. Clin. Infect. Dis. 44 (2007) 904-910
11. Fry A.M., Lu X., Chittaganpitch M., Peret T., Fischer J., Dowell S.F., Anderson L.J., Erdman D., and Olsen S.J. Human bocavirus: a novel parvovirus epidemiologically associated with pneumonia requiring hospitalization in Thailand. J. Infect. Dis. 195 (2007) 1038-1045
12. Khetsuriani N., Kazerouni N.N., Erdman D.D., Lu X., Redd S.C., Anderson L.J., and Teague W.G. Prevalence of viral respiratory tract infections in children with asthma. J. Allergy Clin. Immunol. 119 (2007) 314-321
13. Kupfer B., Vehreschild J., Cornely O., Kaiser R., Plum G., Viazov S., Franzen C., Tillmann R.L., Simon A., Muller A., and Schildgen O. Severe pneumonia and human bocavirus in adult. Emerg. Infect. Dis. 12 (2006) 1614-1616
14. Simon A., Groneck P., Kupfer B., Kaiser R., Plum G., Tillmann R.L., Muller A., and Schildgen O. Detection of bocavirus DNA in nasopharyngeal aspirates of a child with bronchiolitis. J. Infect. 54 (2007) e125-e127
15. Chieochansin T., Chutinimitkul S., Payungporn S., Hiranras T., Samransamruajkit R., Theamboolers A., and Poovorawan Y. Complete coding sequences and phylogenetic analysis of Human bocavirus (HBoV). Virus Res. (2007)
16. 2+ entry by human parvovirus B19 capsid protein VP1. J. Virol. 80 (2006) 11370-11380
17. Canaan S., Zadori Z., Ghomashchi F., Bollinger J., Sadilek M., Moreau M.E., Tijssen P., and Gelb M.H. Interfacial enzymology of parvovirus phospholipases A2. J. Biol. Chem. 279 (2004) 14502-14508
18. Suikkanen S., Antila M., Jaatinen A., Vihinen-Ranta M., and Vuento M. Release of canine parvovirus from endocytic vesicles. Virology 316 (2003) 267-280
19. Dorsch S., Liebisch G., Kaufmann B., von Landenberg P., Hoffmann J.H., Drobnik W., and Modrow S. The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity. J. Virol. 76 (2002) 2014-2018
20. Zadori Z., Szelei J., Lacoste M.C., Li Y., Gariepy S., Raymond P., Allaire M., Nabi I.R., and Tijssen P. A viral phospholipase A2 is required for parvovirus infectivity. Dev. Cell 1 (2001) 291-302
21. Girod A., Wobus C.E., Zadori Z., Ried M., Leike K., Tijssen P., Kleinschmidt J.A., and Hallek M. The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity. J. Gen. Virol. 83 (2002) 973-978
22. Glaser K.B., de Carvalho M.S., Jacobs R.S., Kernan M.R., and Faulkner D.J. Manoalide: structure-activity studies and definition of the pharmacophore for phospholipase A2 inactivation. Mol. Pharmacol. 36 (1989) 782-788
23. Mossner J., Wessig C., Ogami Y., and Keim V. Role of various phospholipases A2 and inhibitors in the pathogenesis and prevention of pancreatic acinar cell necrosis: studies with isolated rat pancreatic acini. Int. J. Pancreatol. 27 (2000) 29-38
24. Ros C., Gerber M., and Kempf C. Conformational changes in the VP1-unique region of native human parvovirus B19 lead to exposure of internal sequences that play a role in virus neutralization and infectivity. J. Virol. 80 (2006) 12017-12024
25. Farr G.A., Zhang L.G., and Tattersall P. Parvoviral virions deploy a capsid-tethered lipolytic enzyme to breach the endosomal membrane during cell entry. Proc. Natl. Acad. Sci. USA 102 (2005) 17148-17153
26. Parker J.S., and Parrish C.R. Canine parvovirus host range is determined by the specific conformation of an additional region of the capsid. J. Virol. 71 (1997) 9214-9222
27. Lu J., Zhi N., Wong S., and Brown K.E. Activation of synoviocytes by the secreted phospholipase A2 motif in the VP1-unique region of parvovirus B19 minor capsid protein. J. Infect. Dis. 193 (2006) 582-590